Post-COVID-19 Brain Health Impaired Versus Healthy Controls
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 28, 2023 -- Brain health after COVID-19 is impaired, but no more than that seen for patients hospitalized for other medical conditions of similar severity, according to a study published online Dec. 28 in JAMA Network Open.
Costanza Peinkhofer, M.D., from Copenhagen University Hospital in Denmark, and colleagues examined whether long-term cognitive, psychiatric, or neurological complications differ for patients hospitalized for COVID-19 versus those hospitalized for other medical conditions of similar severity as well as healthy controls in a prospective cohort study. One hundred twenty patients with COVID-19 were included and matched with 125 patients hospitalized for pneumonia, myocardial infarction, or non-COVID-19 intensive care-requiring illness between March 1, 2020, and June 30, 2021, and 100 healthy age- and sex-matched individuals.
The researchers found that compared with healthy controls, patients with COVID-19 had worse cognitive status (estimated Screen for Cognitive Impairment in Psychiatry [SCIP] score, 59.0 versus 68.8; estimated mean Montreal Cognitive Assessment [MoCA] score, 26.5 versus 28.2); scores were similar when compared with hospitalized controls (mean SCIP score, 61.6; mean MoCA score, 27.2). During all other psychiatric and neurologic assessments, patients with COVID-19 performed worse than healthy controls. The brain health of patients with COVID-19 was not more impaired than among hospitalized control patients, with the exception of executive dysfunction.
"Although studies with broader cognitive test batteries are needed to confirm these findings, brain health after COVID-19 seems overall comparable to that after other diseases of similar severity," the authors write.
Several authors disclosed ties to the Novo Nordisk Foundation and Lundbeck Foundation, both of which partially funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-29 04:15
Read more
- Men Aged >16 to to <55 years at increased risk for acute kidney injury (AKI)
- Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
- Mindfulness Meditation Could Have Direct Effect in Reducing Pain
- ACAAI: Most Syphilis Patients With Penicillin Allergy Have Low Risk for Severe Allergy
- Lithium Aspartate Not Effective for Neurologic Long COVID Fatigue
- Genetic Testing Rate Lower for Blacks With Inherited Retinal Diseases
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions